| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Active Surveillance for Intermediate-Risk Prostate Cancer: Systematic Review and Meta-analysis of Current Protocols and Outcomes
|
Enikeev, Dmitry
|
|
|
18 |
6 |
p. e739-e753
|
article
|
| 2 |
A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients
|
Rakic, Nikola
|
|
|
18 |
6 |
p. 489-499.e6
|
article
|
| 3 |
Characterization of Brain Metastases in Urothelial Cancers
|
Nizam, Amanda
|
|
|
18 |
6 |
p. e679-e683
|
article
|
| 4 |
Chronic Kidney Disease After Partial Nephrectomy in Patients With Preoperative Inconspicuous Renal Function – Curiosity or Relevant Issue?
|
Nientiedt, Malin
|
|
|
18 |
6 |
p. e754-e761
|
article
|
| 5 |
Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non–Clear Cell Renal Cell Carcinoma
|
Gupta, Ruby
|
|
|
18 |
6 |
p. 429-435
|
article
|
| 6 |
Combination Androgen Receptor Inhibition and Docetaxel in Metastatic Castration-sensitive Prostate Cancer: The Next Step in First-line Treatment?
|
Adashek, Jacob J.
|
|
|
18 |
6 |
p. 425-428
|
article
|
| 7 |
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma
|
Palumbo, Carlotta
|
|
|
18 |
6 |
p. e730-e738
|
article
|
| 8 |
Correlation Between Immune-related Adverse Event (IRAE) Occurrence and Clinical Outcome in Patients With Metastatic Renal Cell Carcinoma (mRCC) Treated With Nivolumab: IRAENE Trial, an Italian Multi-institutional Retrospective Study
|
Vitale, Maria Giuseppa
|
|
|
18 |
6 |
p. 477-488
|
article
|
| 9 |
Editorial Board
|
|
|
|
18 |
6 |
p. A1
|
article
|
| 10 |
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care
|
Sterling, Joshua
|
|
|
18 |
6 |
p. e643-e650
|
article
|
| 11 |
Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma
|
Bellmunt Molins, Joaquim
|
|
|
18 |
6 |
p. 452-460
|
article
|
| 12 |
Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial
|
Dumont, Clément
|
|
|
18 |
6 |
p. 444-451
|
article
|
| 13 |
Low-Dose Enzalutamide in Late-Elderly Patients (≥ 75 Years Old) Presenting With Metastatic Castration-Resistant Prostate Cancer
|
Vinh-Hung, Vincent
|
|
|
18 |
6 |
p. e660-e668
|
article
|
| 14 |
Myeloid-Derived Suppressor Cells in Nonmetastatic Urothelial Carcinoma of Bladder Is Associated With Pathologic Complete Response and Overall Survival
|
Fallah, Jaleh
|
|
|
18 |
6 |
p. 500-508
|
article
|
| 15 |
National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer
|
Herrera, Juan C.
|
|
|
18 |
6 |
p. e762-e770
|
article
|
| 16 |
Negative Biopsy Histology in Men With PI-RADS Score 5 in Daily Clinical Practice: Incidence of Granulomatous Prostatitis
|
Pepe, Pietro
|
|
|
18 |
6 |
p. e684-e687
|
article
|
| 17 |
Neoadjuvant Cabozantinib in Renal-Cell Carcinoma: A Brief Review
|
Roy, Arya Mariam
|
|
|
18 |
6 |
p. e688-e691
|
article
|
| 18 |
Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis
|
Patel, Sunil H.
|
|
|
18 |
6 |
p. e723-e729
|
article
|
| 19 |
PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
|
Brown, Landon C.
|
|
|
18 |
6 |
p. 509-513
|
article
|
| 20 |
Phase 2 Trial of GTx-758, an Estrogen Receptor Alpha Agonist, in Men With Castration-Resistant Prostate Cancer
|
Yu, Evan Y.
|
|
|
18 |
6 |
p. 436-443
|
article
|
| 21 |
Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non–muscle-invasive Bladder Cancer
|
Tully, Karl H.
|
|
|
18 |
6 |
p. e651-e659
|
article
|
| 22 |
Safety and Efficacy of Nivolumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
|
McFarlane, Joshua J.
|
|
|
18 |
6 |
p. 469-476.e4
|
article
|
| 23 |
Safety and Efficacy of Nivolumab in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
|
Vogelzang, Nicholas J.
|
|
|
18 |
6 |
p. 461-468.e3
|
article
|
| 24 |
Survival Outcomes for Metastatic Prostate Cancer Patients Treated With Radical Prostatectomy or Radiation Therapy: A SEER-based Study
|
Jin, Kun
|
|
|
18 |
6 |
p. e705-e722
|
article
|
| 25 |
Table of Contents
|
|
|
|
18 |
6 |
p. A3, A4, A6, A8, A10, A12
|
article
|
| 26 |
TFE3 Gene Rearrangement in Perivascular Epithelioid Cell Neoplasm (PEComa) of the Genitourinary Tract
|
Vannucchi, Margherita
|
|
|
18 |
6 |
p. e692-e697
|
article
|
| 27 |
The Impact of 3D Digital Reconstruction on the Surgical Planning of Partial Nephrectomy: A Case-control Study. Still Time for a Novel Surgical Trend?
|
Bianchi, Lorenzo
|
|
|
18 |
6 |
p. e669-e678
|
article
|
| 28 |
The 2020 nccRCC Immunotherapy Issue
|
Hsieh, James J.
|
|
|
18 |
6 |
p. 423-424
|
article
|
| 29 |
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?
|
Roscigno, Marco
|
|
|
18 |
6 |
p. e698-e704
|
article
|
Journal description